Development of radiomics-based models on mammograms with mass lesions to predict prognostically relevant characteristics of invasive breast cancer in a screening cohort
Menée à partir de données portant sur 1 587 tumeurs mammaires invasives et sur 1 095 mammogrammes jugés anormaux, cette étude évalue la performance de modèles prédictifs basés sur des paramètres radiomiques
Background : Optimizing breast-screening performance involves minimizing overdiagnosis of prognostically favorable invasive breast cancer (IBC) that does not need immediate recall and underdiagnosis of prognostically unfavorable IBC that is not recalled timely. We investigated whether mammographic features of masses predict prognostically relevant IBC characteristics.
Methods : In a screening cohort, we obtained pathological information of 1587 IBCs presenting as a mass through the nationwide cancer registry and pathology databank. We developed models based on mammographic tumor appearance to predict whether IBC was prognostically favorable (T1N0M0 luminal A-like) or unfavorable. Models were based on 1095 positive screening mammograms (possible overdiagnosis), or on 603 last negative mammograms with in retrospect visible masses (possible underdiagnosis). We calculated performance metrics using cross-validation.
Results : 23.5 % of masses were prognostically favorable IBC. Using 1095 positive mammograms, the model’s predictions to have prognostically favorable IBC (10th–90th percentile range 8.7–47.0%) yielded AUC 0.75 (SD across repeats 0.01), slope 1.16 (SD 0.07). Performance in 603 last negative screening mammograms with masses was poor: AUC 0.60 (SD 0.02), slope 0.85 (SD 0.28).
Conclusions : Mammography-based models from masses representing IBC at time of recall (possible overdiagnosis) predict prognostically relevant characteristics of IBC. Models based on in retrospect visible masses (possible underdiagnosis) performed poorly.
British Journal of Cancer , résumé 2025